Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission setting

Abstract Background There remain gaps in quantifying mortality risk among individuals co-infected with chronic hepatitis B (HBV) and human immunodeficiency virus (HIV) in sub-Saharan African contexts. Among a cohort of HIV-positive individuals in Rwanda, we estimate the difference in time-to mortali...

Full description

Bibliographic Details
Main Authors: Justine Umutesi, Sabin Nsanzimana, Carol Yingkai Liu, Patrizio Vanella, Jördis J. Ott, Gérard Krause
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-022-07477-1
_version_ 1818206979354525696
author Justine Umutesi
Sabin Nsanzimana
Carol Yingkai Liu
Patrizio Vanella
Jördis J. Ott
Gérard Krause
author_facet Justine Umutesi
Sabin Nsanzimana
Carol Yingkai Liu
Patrizio Vanella
Jördis J. Ott
Gérard Krause
author_sort Justine Umutesi
collection DOAJ
description Abstract Background There remain gaps in quantifying mortality risk among individuals co-infected with chronic hepatitis B (HBV) and human immunodeficiency virus (HIV) in sub-Saharan African contexts. Among a cohort of HIV-positive individuals in Rwanda, we estimate the difference in time-to mortality between HBV-positive (HIV/HBV co-infected) and HBV-negative (HIV mono-infected) individuals. Methods Using a dataset of HIV-infected adults screened for hepatitis B surface antigen (HBsAg) from January to June 2016 in Rwanda, we performed time-to-event analysis from the date of HBsAg results until death or end of study (31 December 2019). We used the Kaplan–Meier method to estimate probability of survival over time and Cox proportional hazard models to adjust for other factors associated with mortality. Results Of 21,105 available entries, 18,459 (87.5%) met the inclusion criteria. Mean age was 42.3 years (SD = 11.4) and 394 (2.1%) died during follow-up (mortality rate = 45.7 per 100,000 person-months, 95% confidence interval (CI) 41.4–50.4) Mortality rate ratio for co-infection was 1.7, 95% CI 1.1–2.6, however, Cox regression analysis did not show any association with mortality between compared groups. The adjusted analysis of covariates stratified by co-infection status showed that males, residing outside of the capital Kigali, drinking alcohol, WHO-HIV-clinical stage 3 and 4 were associated with increased mortality in this HIV cohort. Conclusions HBV infection does not significantly influence mortality among HIV-infected individuals in Rwanda. The current cohort is likely to have survived a period of high-risk exposure to HBV and HIV mortality and limited health care until their diagnosis.
first_indexed 2024-12-12T04:21:38Z
format Article
id doaj.art-a7c450275f5f4db093b55197d5e8a517
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-12-12T04:21:38Z
publishDate 2022-05-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-a7c450275f5f4db093b55197d5e8a5172022-12-22T00:38:19ZengBMCBMC Infectious Diseases1471-23342022-05-0122111010.1186/s12879-022-07477-1Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission settingJustine Umutesi0Sabin Nsanzimana1Carol Yingkai Liu2Patrizio Vanella3Jördis J. Ott4Gérard Krause5Helmholtz Centre for Infection Research (HZI)-PhD Program “Epidemiology”Rwanda Biomedical CenterDepartment of Epidemiology, Emory University Rollins School of Public HealthDepartment of Epidemiology, Helmholtz-Zentrum Für Infektionsforschung GmbH (4214)Department of Epidemiology, Helmholtz-Zentrum Für Infektionsforschung GmbH (4214)Department of Epidemiology, Helmholtz-Zentrum Für Infektionsforschung GmbH (4214)Abstract Background There remain gaps in quantifying mortality risk among individuals co-infected with chronic hepatitis B (HBV) and human immunodeficiency virus (HIV) in sub-Saharan African contexts. Among a cohort of HIV-positive individuals in Rwanda, we estimate the difference in time-to mortality between HBV-positive (HIV/HBV co-infected) and HBV-negative (HIV mono-infected) individuals. Methods Using a dataset of HIV-infected adults screened for hepatitis B surface antigen (HBsAg) from January to June 2016 in Rwanda, we performed time-to-event analysis from the date of HBsAg results until death or end of study (31 December 2019). We used the Kaplan–Meier method to estimate probability of survival over time and Cox proportional hazard models to adjust for other factors associated with mortality. Results Of 21,105 available entries, 18,459 (87.5%) met the inclusion criteria. Mean age was 42.3 years (SD = 11.4) and 394 (2.1%) died during follow-up (mortality rate = 45.7 per 100,000 person-months, 95% confidence interval (CI) 41.4–50.4) Mortality rate ratio for co-infection was 1.7, 95% CI 1.1–2.6, however, Cox regression analysis did not show any association with mortality between compared groups. The adjusted analysis of covariates stratified by co-infection status showed that males, residing outside of the capital Kigali, drinking alcohol, WHO-HIV-clinical stage 3 and 4 were associated with increased mortality in this HIV cohort. Conclusions HBV infection does not significantly influence mortality among HIV-infected individuals in Rwanda. The current cohort is likely to have survived a period of high-risk exposure to HBV and HIV mortality and limited health care until their diagnosis.https://doi.org/10.1186/s12879-022-07477-1Chronic hepatitis BMortalityHIVCohort studySub-Saharan AfricaRwanda
spellingShingle Justine Umutesi
Sabin Nsanzimana
Carol Yingkai Liu
Patrizio Vanella
Jördis J. Ott
Gérard Krause
Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission setting
BMC Infectious Diseases
Chronic hepatitis B
Mortality
HIV
Cohort study
Sub-Saharan Africa
Rwanda
title Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission setting
title_full Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission setting
title_fullStr Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission setting
title_full_unstemmed Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission setting
title_short Long-term effect of chronic hepatitis B on mortality in HIV-infected persons in a differential HBV transmission setting
title_sort long term effect of chronic hepatitis b on mortality in hiv infected persons in a differential hbv transmission setting
topic Chronic hepatitis B
Mortality
HIV
Cohort study
Sub-Saharan Africa
Rwanda
url https://doi.org/10.1186/s12879-022-07477-1
work_keys_str_mv AT justineumutesi longtermeffectofchronichepatitisbonmortalityinhivinfectedpersonsinadifferentialhbvtransmissionsetting
AT sabinnsanzimana longtermeffectofchronichepatitisbonmortalityinhivinfectedpersonsinadifferentialhbvtransmissionsetting
AT carolyingkailiu longtermeffectofchronichepatitisbonmortalityinhivinfectedpersonsinadifferentialhbvtransmissionsetting
AT patriziovanella longtermeffectofchronichepatitisbonmortalityinhivinfectedpersonsinadifferentialhbvtransmissionsetting
AT jordisjott longtermeffectofchronichepatitisbonmortalityinhivinfectedpersonsinadifferentialhbvtransmissionsetting
AT gerardkrause longtermeffectofchronichepatitisbonmortalityinhivinfectedpersonsinadifferentialhbvtransmissionsetting